| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| ALIBABA LITIGATION | 153 | 153 | 0 |
| ADR FX LITIGATION | 43 | 43 | 0 |
| BNY MELLON LITIGATION | 265 | 265 | 0 |
| DIPLOMAT PHARMACY | 526 | 526 | 0 |
| EQUIFAX LITIGATION | 10,817 | 10,817 | 0 |
| INTUITIVE SURGICAL LITIGATION | 29 | 29 | 0 |
| K-12 2019 LITIGATION | 58 | 58 | 0 |
| LIFELOCK | 929 | 929 | 0 |
| WELLS FARGO LITIGATION | 225 | 225 | 0 |
| ZIMMER BIOMET LITIGATION | 1,230 | 1,230 | 0 |
| OTHER INCOME | 62 | 62 | 0 |